Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-04-29
1998-12-08
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241551, 4241561, 435 696, 435 7021, 4351722, 4351723, 435328, 5303873, 5303888, 53038885, A61K 39395, G07K 1630
Patent
active
058465340
ABSTRACT:
An antibody is produced, which will bind effectively with the antigen Campath-1, and which has at least one complementarity determining region of rat origin, as identified in FIG. 2, which may be combined with a range of different foreign variable domain framework regions as desired, including framework regions of human origin.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5225539 (1993-07-01), Winter
Steplewski et al. "Biological activity of human-mouse IgG1 . . . " Proc. Natl. Acad. of Sci. USA, 1988, 85, pp. 4852-4856.
Dangl et al. "Segmental flexibility and complement fixation . . . " EMBO Journal, 1988, 7, pp. 1989-1994.
G. Hale et al. "Removal of T Cells from bone marrow . . . " Mol. Biol. Med. 1983, 1, pp. 305-319.
G. Hale et al. "Removal of T Cells from bone marrow . . . " Blood, 1983, 62, pp. 873-882.
G. Hale et al. "Pilot study of Campath-1, . . . " Transplantation, 1986, 42, pp. 308-311.
G. Hale et al. "Remission induction in non-Hodgkin . . . " The Lancet, Dec. 17, 1988, pp. 1394-1399.
V.N. Schumaker et al. "Ultracentrifuge studies of the binding of IgG . . . , " Biochemistry, 1976, 15, pp. 5175-5181.
A.Y. Liu et al. "Chimeric mouse-human IgG1 . . . " Proc. Natl Acad. of Sci. USA, 1987, 84, pp. 3499-3442.
D.R. Shaw et al. "Characterization of a mouse-human chimeric . . . " Jour of Immunol, 1987, 138, pp. 4534-4538.
M. Bruggemann et al. "Comparison of the effector functions of human . . . " J. Exp. Med., 1987, 166, pp. 1351-1361.
C.I. Bindon et al. "Human monoclonal IgG isotype . . . " J. Exp. Med., 1988, 168, pp. 127-142.
J.F. Apperley et al. "Bond marrow transplantation for patients with chronic myeloid leukemia . . . " Bone Marrow Transplantation, (1986), 1, pp. 53-66.
G. Papa et al. "Standard conditioning regimen and T-depleted . . . " Leukemia Research, vol. 10 No. 12, 1986, pp. 1469-1475.
G. Bandini et al. "T-Cell depletion with the monoclonal . . . " Haematologica, 1986, 71, pp. 307-312.
S. Slavin et al. "New approaches for the prevention of . . . " New Approaches in Marrow Transplantation, vol. 22 Nos. 3-4, Mar.-Apr. 1986, pp. 264-267.
G. Morgan et al. "Successful haploidentical mismatched . . . " Bri. Jour of Haematology, 1986, 62, pp. 421-430.
R. J. Levinsky. "Recent advances in bone marrow transplantation" Clinical Immunol & Immunopathology, 50, (1989), pp. S124-S132.
G. Hale et al. "Campath-1 for prevention of graft-versus . . . " Bone Marrow Transplant, 1988, 3(s1), pp. 11-14.
G. Hale et al. "Therapeutic potential of rat monoclonal . . . " The Jour of Immunol., vol. 134 No. 5, May 1985, pp. 3056-3061.
P.J. Friend et al. "Successful treatment of renal . . . " Transplantation Proc. vol. 27 No. 1(Feb. 1995) pp. 869-870.
A. Fast et al. "Haploidentical bone marrow . . . " Bone Marrow Transplant, 1988, 3(S1), p. 141.
Hale et al., "Isolation of Low Frequency Class-Switch Variants From Rat Hybrid Myelomas," J. Immunol.Meth. 103:59-67, 1987.
Roberts et al., "Generation of an Antibody with Enhanced Affinity and Specificity for its Antigen by Protein Engineering," Nature 328:731-734, 20 Aug. 1987.
Hale et al., "Effects of Monoclonal Anti-Lymphocyte Antibodies In Vivo in Monkeys and Humans," Mol. Biol. Med. 1:321-334, 1983.
G. Hale et al. "Effects of monoclonal anti-lymphocyte . . . " Mol. Bio. Med.(1983)1, pp. 321-334.
L. Reichmann et al. "Reshaping human antibodies . . . " Nature, vol. 332, 24 Mar. 1988, pp. 323-327.
P.T. Jones et al. "Replacing the complementarily-determining . . . " Nature, vol. 321, 29 May 1986, pp. 522-525.
M. Verhoeyen et al, "Reshaping human antibodies . . . " Science, vol. 239, 25 Mar. 1988, pp. 1534-1536.
Clark Michael R.
Riechmann Lutz
Waldmann Herman
Winter Gregory P.
British Technology Group Limited
Budens Robert D.
LandOfFree
Antibodies to the antigen campath-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to the antigen campath-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to the antigen campath-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174562